Completed PHASE4 INTERVENTIONAL 2-arm NCT00658203

Clinical Evaluation on Advanced Resynchronization

Sponsor: LivaNova

Updated 6 times since 2017 Last updated: Apr 7, 2008 Started: Nov 30, 2005 Primary completion: Feb 29, 2008 Completion: Feb 29, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Cardiomyopathy and Heart Failure and is currently completed. LivaNova leads this study, which shows 6 recorded versions since 2005 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Nov 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

LivaNova

Data source: LivaNova

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Albi, France , Alicante, Spain , Angers, France , Berlin, Germany , Bordeaux, France , Bournemouth, United Kingdom , Carpi, Italy , Chertsey, United Kingdom , Desio, Italy , Eastbourne, United Kingdom and 24 more locations